Hana Ross, PhD American Cancer Society and the International Tobacco Evidence Network (ITEN)

Similar documents
The Economics of Tobacco and Tobacco Taxation in Bangladesh: Abul Barkat et.al

Tobacco Health Cost in Egypt

THE ECONOMICS OF TOBACCO AND TOBACCO TAXATION IN BANGLADESH

Appendix. Background Information: New Zealand s Tobacco Control Programme. Report from the Ministry of Health

Facts & Issues. Tobacco in Australia. A comprehensive online resource. tobaccoinaustralia.org.au

TOBACCO CONTROL ECONOMICS TOBACCO FREE INITIATIVE PREVENTION OF NONCOMMUNICABLE DISEASES

Chapter 1. Introduction. Teh-wei Hu

Tobacco & Poverty. Tobacco Use Makes the Poor Poorer; Tobacco Tax Increases Can Change That. Introduction. Impacts of Tobacco Use on the Poor

Impact of excise tax on price, consumption and revenue

Potential Costs and Benefits of Smoking Cessation for New Jersey

THE ECONOMICS OF TOBACCO AND TOBACCO CONTROL, A DEVELOPMENT ISSUE. ANNETTE DIXON, WORLD BANK DIRECTOR, HUMAN DEVELOPMENT SECTOR

T he adverse health effects of cigarette smoking have been

The alcohol market is in need of a thorough review

Tobacco and Poverty. Anne-Marie Perucic WHO/Tobacco Free Initiative

Amendment 72 Increase Cigarette and Tobacco Taxes

T obacco use is one of the most important contributors to

The Social Cost of Smoking in Singapore

ECONOMICS Component 2 Exploring Economic Issues

How to evaluate the economic impact of interventions I: introduction and costing analyses

GATS Highlights. GATS Objectives. GATS Methodology

THE COST OF ALCOHOL RELATED PROBLEMS IN IRELAND

Open Letter to Financial Secretary, Hong Kong SAR Government

The Devastating Toll of Tobacco

New Jersey s Comprehensive Tobacco Control Program: Importance of Sustained Funding

The Economics of Alcohol and Cancer/Chronic Disease

Where We Are: State of Tobacco Control and Prevention

Impact of health behaviours and health interventions on demand for and cost of NHS services in the North of Scotland (including Tayside)

Effective spending to reduce the burden of chronic diseases: the pressure on health and social systems

Tobacco Data, Prevention Spending, and the Toll of Tobacco Use in North Carolina

RADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS

2015 Pre Budget Submission

Save Lives and Save Money

Raising Tobacco Taxes A Summary of Evidence from the NCI-WHO Monograph on the Economics of Tobacco and Tobacco Control

International Review of the Health and Economic Impact of the Regulation of Smoking in Public Places

The Cost of Tobacco in Nova Scotia: An Update

THE PERRYMAN GROUP. 510 N. Valley Mills Dr., Suite 300. Waco, TX ph , fax

MENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division

Oklahoma Turning Point Council (OTPC)

Tobacco Control Costs of Smoking in Hull and East Riding of Yorkshire

Reducing Tobacco Use and Secondhand Smoke Exposure: Interventions to Increase the Unit Price for Tobacco Products

Making Your Business Tobacco Free

Economic Evaluation. Defining the Scope of a Costeffectiveness

Submission on behalf of: Cancer Society of New Zealand. Claire Austin Chief Executive. Contact person. Shayne Nahu

WHAT IS NO BUTTS ABOUT IT?

State of provision of Hearing Aids in Europe

The Independent British Vape Trade Association (IBVTA) welcomes the opportunity to respond to this consultation.

Healthy People, Healthy Communities

Impacts What could a systemic approach to smoking cessation mean for Victoria? Sarah White, PhD Director, Quit Victoria

The Cigarette Market in Greece

Recent Findings from the ITC Project on the Effectiveness of Health Warnings in the Asia Pacific Region

Executive Summary. Overall conclusions of this report include:

Tobacco use is Wisconsin s

n/e/r/a ALCOHOL IN LONDON: A COST-BENEFIT ANALYSIS A Final Report for the Greater London Authority Prepared by NERA January 2003 London

Counting the costs of tobacco and the benefits of reducing smoking prevalence in Western Australia

The Economic Consequences of Diabetes: More than just a health issue

Jad Chaaban Assistant Professor Department of Agriculture. Nisreen Salti Assistant Professor Department of Economics

18 The effectiveness and cost-effectiveness of price increases and other tobaccocontrol

Comprehensive Tobacco Control Programs: Economic Review. Page 1 of 26. Study Info Intervention Characteristics Population Characteristics

Global burden and costeffective. tobacco control" Dr Douglas Bettcher Director Prevention of Noncommunicable Diseases World Health Organization

Asia Illicit Tobacco Indicator 2016: Hong Kong. Prepared by Oxford Economics October 2017

FACT SHEET Alcohol and Price. Background. 55 million European adults drink to dangerous levels.

Economic Analysis of Interventions for Smoking Cessation Aimed at Pregnant Women

The Healthy Indiana Plan

August 2009 Ceri J. Phillips and Andrew Bloodworth

ACTION PLAN. Intergovernmental Coordinating Body, Ministry of Finance. Intergovernmental Coordinating Body, Ministry of Finance

Global Adult Tobacco Survey TURKEY. Dr. Peyman ALTAN MoH Tobacco Control Dep. Ankara November 2018

Tobacco Control in Developing Countries

The health economic landscape of cancer in Europe

Employee Handbook of the Royal College of Physicians of Ireland. RCPI Policy Group on Alcohol Pre Budget Submission

CANNABIS IN ONTARIO S COMMUNITIES

Estimating the economic value of reducing smoking rates in Canada to 18% and the cost of failing to achieve the 12% goal.

Fast Facts. Morbidity and Mortality (Related to Tobacco Use)

Get the Facts: Minnesota s 2013 Tobacco Tax Increase is Improving Health

Reducing Tobacco Use and Secondhand Smoke Exposure: Smoke- Free Policies

Expenditure Share United States, 2003

Nisreen Salti Associate Professor Department of Economics American University of Beirut

Tobacco Product Regulation: FDA s Economic Impact Analysis Frank J. Chaloupka University of Illinois at Chicago

SMOKING, HEALTHCARE COST AND LOSS OF PRODUCTIVITY IN INDONESIA Created by: dr. DIAH EVASARI HUSNULKHOTIMAH, MPH

TOBACCO TAXATION, TOBACCO CONTROL POLICY, AND TOBACCO USE

Why has the Commission presented these fundamental proposals for change to the system of excise duty on tobacco?

The Effectiveness of Tobacco Tax & Price Policies for Tobacco Control Frank J. Chaloupka University of Illinois at Chicago

Guideline scope Smoking cessation interventions and services

ISBN: Centre for Tobacco Control in Africa (CTCA), 2017

The Global Tobacco Problem

Cigarettes. Ada Ellisman, Bryan Gibson, & Evie White

Fraser of Allander Institute

Title: Tobacco taxation policies in the Former USSR countries. Final technical report. July 2013: Location: Kiev, Ukraine

The burden and cost of cancer

Tobacco, Development, and the Canadian Experience

Cigarette Consumption in China ( ) Cigarette Consumption in Poland ( )

TOBACCO CONTROL & THE SUSTAINABLE DEVELOPMENT GOALS

December 2012 Prepared by:

CENTRE FOR ECONOMIC RESEARCH WORKING PAPER SERIES

Reducing Tobacco Use and Secondhand Smoke Exposure: Reducing Out-of-Pocket Costs for Evidence Based Tobacco Cessation Treatments

Reducing smoking: crucial to a successful Community Improvement Plan

Diabetes mellitus is a disorder caused by insufficient or non

Local Laws to Raise the Minimum Legal Sale Age for all Tobacco Products 21 Years of Age in the North Country Frequently Asked Questions

Substance Misuse in New Hampshire: An Update on Costs to the State s Economy and Initial Impacts of Public Policies to Reduce Them

Costing the burden of ill health related to physical inactivity for Scotland

Transcription:

The Costs of Smoking Hana Ross, PhD American Cancer Society and the International Tobacco Evidence Network (ITEN) Why Do We Study the Cost of Smoking? To assess the economic impact of smoking behavior on: Society (macro economy) Individuals (economy of a household) State budget (public finances) Business/employers Perspective of each entity will determine what will be included in the costs Societal perspective is most comprehensive 2 1

Classification of Costs Direct costs: reduction in existing resources (existing resources are diminished; e.g., goods and services in health care) Direct health care costs (e.g., medicines) Direct non health care costs (e.g., transportation to clinic, time of family members providing care) Indirect or productivity costs: reduction in potential resources (due to premature morbidity or mortality) 3 Examples of Direct Costs Direct health care costs Hospital services (e.g., inpatient, outpatient) Outpatient services (e.g., primary care doctor visits) Prescription and nonprescription drugs Long-term care (e.g., nursing homes) Other direct costs Transportation costs to receive medical care Time of family members spent providing care Food expenses connected to medical care Fire Welfare provisions (sick pay, disability pay) 4 2

Examples of Indirect Costs Production losses resulting from: Premature death Sickness Other reduced productivity (e.g., time spent smoking, reduced health status of smokers) 5 Other Classification of Costs External costs: costs that smokers imposed on others without compensation (e.g., costs related to secondhand smoke) These costs constitute the rationale for taxation Internal costs: costs paid for by smokers (and their families) incurred as a result of smoking (e.g., costs of cigarette purchases for smokers who would like to quit and are unable to do so) These costs relate to utility from smoking Taxes can correct internalities for addictive substances such as tobacco products 6 3

Other Classification of Costs Tangible costs: existing resources that are diminished These resources have a market price (e.g., costs of treatment for smoking-related illness or reduced access to health care for others due to the diversion of limited resources) Intangible costs: do not reduce existing resources, are difficult to value (e.g., pain and suffering) 7 Other Classification of Costs Avoidable costs: these costs can be avoided if the most efficient health policies were implemented and maintained over an extended period of time (e.g., cessation) Unavoidable costs: costs which are currently borne relating to past abuse, and costs incurred by the proportion of the population who will continue to smoke 8 4

What Are Health Care Costs Attributable to Smoking? Incidence-based approach: Net health care costs of smoking: additional costs across the full lifespan of a smoker, compared with costs for that same person as a hypothetical nonsmoker ( Death Benefit argument) Prevalence-based approach: Gross health care costs of smoking: actual expenditures for additional health care provided across a given time period because of smoking by the population (smoking attributable fraction) 9 Lifetime Costs of Smoking: The Death Benefit Issue The argument is: Smokers, on average, do not live as long as nonsmokers Over the lifespan of smokers, health care costs are not greater than costs for nonsmokers, but expenditures are more rapid Smokers pay the same into retirement and other systems compared with nonsmokers (not if smokers die in productive age) Therefore, nonsmokers and governments benefit from their premature deaths the so-called Death Benefit argument But the value of money and future treatment costs need to be taken into account 10 5

The Death Benefit Issue: Case Study Philip Morris study of smoking in the Czech Republic (2001) State budget perspective (narrow focus) Results Net benefit of $150 million due to tax income (smokers and industry) and premature deaths Included health care costs, lost income tax, paid sick leave, and property loss due to fire (but not all costs) Source: Ross, H. (2004). 11 The Death Benefit Issue: Case Study Critique Not included: costs imposed on families (lost income, out-ofpocket costs of treatment, costs for buying cigarettes) and lost productivity due to illness Implies that the value of a retired person s life is zero Taxes do not represent a new value but an income redistribution (taxes can be collected from different products; tobacco does not need to be consumed in order to collect taxes) If taxes are left out from the Philip Morris study, smoking would cost the government 13 times more than what it would save Source: Ross, H. (2004). 12 6

Smoking Attributable Fraction (SAF) SAF: the fraction of health care costs resulting from smoking Method of estimating the excess health care costs (prevalencebased approach) Estimate total or disease-specific costs Reduce the total costs in three steps 1. Eliminate nonsmokers 2. Eliminate diseases among smokers not caused by smoking 3. Subtract average health care costs for the population 13 Calculation of SAF Lung cancer No lung cancer Total Smoker 140 4,860 5,000 Never smoker 20 4,980 5,000 Total 160 9,840 10,000 Of lung cancer cases, 140 out of 160 occur in smokers 140/160 = 87.5% First reduction of total costs is by 87.5% 14 7

Calculation of SAF Lung cancer No lung cancer Total Smoker 140 4,860 5,000 Never smoker 20 4,980 5,000 Total 160 9,840 10,000 How much extra disease? Only 120 out of the 140 cases in smokers are attributable to smoking (since 20 nonsmokers also got lung cancer) 120/140 = 85.7% Second reduction of total costs is by 85.7% 15 Calculation of SAF How much extra health care costs? Example In 1987, average cost for lung cancer patient = $15,000 In 1987, average health care cost per person = $700 $15,000 $700 = $14,300 $14,300/$15,000 = 95.3% Third reduction of total costs is by 95.3% 16 8

Calculation of SAF Assume total lung cancer expenditures in 1987: $2.4 million First reduction by 87.5% to include only smokers: $2.1 million Second reduction by 85.7% to count only the cases among smokers, taking into account the nonsmoking population: $1.8 million Third reduction by 95.3% to count only excess health care costs: $1.7 million Smoking-attributable fraction: $1.7 million/$2.4 million = 71.5% 17 Global Evidence on Health Care Costs from Smoking Studies using the prevalence-based approach Annual (gross) health care costs represent 0.1% to 1.1% of GDP, or 6% to 15% of total health costs Studies using the incidence-based approach Differences in lifetime costs are smaller than annual costs Most studies consider only health care costs, not the other internal, external, and intangible costs Best studies do suggest that there are net lifetime costs Source: Lightwood, J., et al. (2000). 18 9

Research Evidence on Health Costs: Europe Costs of smoking in EU25 countries Method: prevalence-based approach contrasting results of two approaches SAF of direct and indirect costs for treatment of respiratory and heart diseases in EU15 and extrapolation to EU25 Extrapolation of direct and indirect costs of smoking in Germany Results: smoking costs EU25 1.04% to 1.39% of GDP, or 211 to 281, per capita per year Source: Tobacco or Health in the European Union Past, Present and Future. (2004). 19 Research Evidence on Health Costs: Europe Cost of workplace smoking in Ireland Method: macro-level estimates of smoking-related excess absenteeism, reduced productivity, and foregone output arising from premature mortality are combined with data on average income and employment rate; no health care costs Results: 1,237 million to 1,886 million (1.1% to 1.7% of Irish GDP in 2000) Source: Madden, D. (2002). 20 10

Research Evidence on Health Costs: Europe Cost of workplace smoking in Scotland Method: micro-level estimates of smoking-related excess absenteeism, reduced productivity, and cost of fire hazards are combined with data on average income and employment rate; no health care costs Results: 437 million to 652 million (0.51% to 0.77% of Scottish GDP in 1997) 21 Research Evidence on Health Costs: Europe Net (lifetime) health care costs in Denmark Method: incidence-based approach Results: direct and indirect lifetime health costs were 66% and 83% higher in ever smokers than in never smokers for men aged 35; for women, these estimates were 74% and 79%, respectively Source: Rasmussen, S. (2004). 22 11

Health Care Costs from Smoking: Taiwan Methods: prevalence-based approach to calculate SAF of costs on medical care and loss of productivity due to premature death Results: 6.8% of total health costs attributable to smoking The total smoking attributable cost was U.S. $1.79 billion in 2001 Source: Yang, et al. (2005). 23 Health Care Costs from Smoking: Korea Method 1: disease-specific approach Direct and indirect costs of treating cancer and cardiovascular, respiratory, and gastrointestinal diseases attributable to smoking using the population attributable risk (PAR) Method 2: all-causes approach Compare the differences in direct and indirect costs between smokers and nonsmokers for all conditions and types of disease Results: 0.6% to 0.8% of GDP using disease-specific approach and 0.8% to 1.2% of GDP using all-causes approach Source: Kang, et al. (2003). 24 12

Health Care Costs from Smoking: Hong Kong Method: active and passive SAF is linked to mortality; hospital admissions; outpatient, emergency, and general practitioner visits for adults and children; use of nursing homes and domestic help; time lost from work due to illness and premature mortality in the productive age Work time lost was valued at the median wage Results: productivity losses due to active and passive smoking HK$1,773 billion per year; total direct health care and long-term care costs HK$3,572 billion per year; about 28% health care cost due to passive smoking; about 50% of all costs fall on public sector; government revenue from tobacco duty is only HK$2.5 billion per year Source: McGhee, et al. (2006). 25 Summary Costs of smoking are subject to multiple classification Understanding these classifications is important for defining research objectives and for critical evaluation of research results The majority of studies focus on the health care costs of smoking because they are of most interest to policy makers and are easier to quantify However, health care costs constitute only a fraction of the total costs of smoking Not all costs related to smoking-related diseases can be attributed to smoking 26 13

Summary There is a delay factor between the onset of smoking and costs imposed on the smoker, his/her family, and society Most studies have limitations and underestimate the true costs of smoking The conservative estimates of smoking costs in most countries in which studies have been conducted range from 0.1% to 1.1% of GDP, or 6% to 15% of total health care costs These costs will be increasing in the future due to the upward trend in health care spending 27 14